I am sure that most of us believed that approval and acceptance of EDEN would come much faster. I'm not certain that the company believed that, or not. I don't know if back in say 2020, after acquiring FlaskWorks if they said we anticipate it can be approved by 2024 or 2025, if they wouldn't have lost a lot of investors support.
Most every biotech I've observed have taken much longer than investors thought to get anything done, but the rewards were there after success in nearly every case.
Gary
Market Data 
Markets 
AI
